Urologic Oncology Fellowship
The Urologic Oncology Fellowship program at UCSF offers multidisciplinary training in all aspects of urologic oncology. The program consists of one year of laboratory research and at least one year of clinical urologic oncology. The fellowship program is accredited by the Society of Urologic Oncology.
Our basic science research efforts are predominately focused on prostate cancer, bladder cancer and renal cell carcinoma. Several nationally recognized scientists participate in these efforts with considerable funding from the National Institutes of Health. Our prostate cancer program is further supported by one of the few Special Projects in Research Excellence (SPORE) grants awarded in prostate cancer research. In addition to basic science research, opportunities exist for clinical research and outcomes research through the UCSF Urology Outcomes Research Group. Candidates for fellowship have a wide array of research opportunities available to them including androgen receptor biology, genomic alterations, tumor immunology, Phase I evaluation of novel drugs, and biomarker identification and validation. Although not required, previous fellows have successfully received American Foundation for Urologic Diseases (AFUD) grants.
The clinical rotation provides a broad exposure to all aspects of urologic oncology. The fellow participates in the operating room, in outpatient evaluation and management and in conferences. The program offered is multidisciplinary and provides instruction and support for the disciplines of radiology, radiation oncology, medical oncology and urologic oncology. The clinical service is very busy and provides an opportunity for the fellow to participate in all types of urologic oncology operative procedures including major open surgery, complex reconstruction and laparoscopic oncology. The majority of clinical work is performed at the UCSF Bakar Cancer Center at Mission Bay, but fellows also participate in oncology cases at the UCSF Parnassus Campus Moffitt Hospital, San Francisco Veterans Administration Hospital and at San Francisco General Hospital. Our program is closely tied to departmental activities, and as a result, the oncology fellow is able to benefit from the expertise of the entire faculty.
We participate in the SUO (Society of Urologic Oncology fellowship match) process administered by the American Urological Association (AUA).
Program Prerequisites/ Preferences
- Candidate must have completed an ACGME Urology Residency Training Program
- Candidate must be a US citizen due to the funding of the position
- Special interest in future academic and scholarly activities is considered highly favorable
- Preferably be a candidate for the American Board of Urology
- Candidate must be eligible to obtain a California medical license (please refer to the CA Medical Board for eligibility requirements)
Applications are due March 1st of each year, 16 months prior to beginning fellowship.
Application Packets should include:
- Cover Letter
- SUO (Society of Urologic Oncology) application
- Curriculum Vitae
- Personal Statement
- A headshot photo (jpeg)
- (3) three letters of reference
Submit application packets via email to Sima P. Porten MD, MPH (Fellowship Program Director), Maxwell Meng, MD (Associate Program Director), c/o Katherine Jung, [email protected].
2023 Match Information
**Dr. Sima Porten became the Fellowship Program Director in February 2022. Dr. Maxwell Meng is involved with the program as the Associate Program Director.**
- Wednesday, April 6, 2022
- Saturday, April 9, 2022
Julie A. Szymaniak, MD
|Avery Braun, D0
7/1/2022 - 6/30/2024
2022, Einstein Healthcare Network
2017, Ohio University Heritage College of Osteopathic Medicine
Scott Greenberg, MD
|Peter Lonergan, MD
Clinical Oncology Fellow 2019-2021
Consultant Urological Surgeon and Clinical Senior Lecturer
St. James's Hospital and Trinity College, Dublin, Ireland
|Samuel L. Washington III, MD, MAS
Clinical Oncology Fellow 2018-2020
Assistant Professor, Department of Urology, University of California, San Francisco, CA
|Annika Herlemann, MD, PhD
Clinical Oncology Fellow 2018-2019
Faculty, Ludwig Maximilian University of Munich, Germany
|Renu Eapen, MBBS
Clinical Oncology Fellow 2016-2017
Attending Physician, Cancer Specialists, Australia
Consulting Physician, Peter MacCallum Cancer Centre and The Austin Hospital, Australia
|Michael Leapman, MD
Clinical Oncology Fellow 2014-2016
Faculty, Yale University, New Haven, CT
To view past clinical/research fellows trained, click here.